Evidence map›Paper›PMID 30019489›Full record

ArticleJournal of neuroscience research2018

Changes in ganglioside GM1 expression in glaucomic retina.

Nate Pappenhagen, Denise M Inman

Open access · bronzeAbstract readLetter
In one paragraph

Article in Journal of neuroscience research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nate PappenhagenSchool of Biomedical Sciences, Kent State University, Kent, Ohio.ORCID 0000-0003-4310-4371
Denise M InmanDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio.ORCID 0000-0002-8522-4112
Kent State University · USNortheast Ohio Medical University · US

Funding

Metabolic vulnerability as a disease target for glaucomaR01EY026662 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI DENISE M INMAN · 2016 to 2026
$4.1M
NEI NIH HHS R01 EY026662NEI NIH HHS R01: NIH EY-026662
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCentral Nervous SystemGlaucomaG(M1) GangliosideHumansMiceMice, Inbred DBANeurogliaRetinaRetinal Ganglion CellsUp-RegulationG(M1) Ganglioside

Identifiers

PMID30019489
PMCPMC6129427
OpenAlexW2884295458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.